GlaxoSmithKline share price logo

GlaxoSmithKline

NYSE: GSK

Large Cap

$47.79

-0.79

(-1.63%)

Live

as on

GlaxoSmithKline Stock Performance

as on November 20, 2026 at 7:31 am IST

  • Day's Low

    Day's High

    $47.68
    $48.44
    downward going graph

    0.23%

    Downside

    1.36%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $45.81
    $61.70
    downward going graph

    4.15%

    Downside

    29.10%

    Upside

    downward going graph

GlaxoSmithKline share price movements today

Previous Close
$48.58
Open
$48.28
Volume
2.2M
Market Cap
$98.9B
Dividend Yield
3.73%
Day's Low - High
$47.68 - $48.44
52 Week Low - High
$45.81 - $61.70

GlaxoSmithKline Historical Returns

1 Month Return
-1.78 %
3 Month Return
-8.13 %
1 Year Return
+ 4.83 %
3 Year Return
+ 38.01 %
5 Year Return
-6.55 %

GlaxoSmithKline Stock Fundamentals & Key Indicators

Check GlaxoSmithKline market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$98.9B

EPS (TTM)

2.16

Dividend Yield

3.73%

Quarterly Earnings Growth YOY

-0.23%

PE Ratio (TTM)

17.31

Industry PE ratio

9.71

PEG Ratio

-0.84

EBITDA

8.7B

Revenue (TTM)

33.5B

Profit Margin

73.52%

Return On Equity TTM

24.64%

GlaxoSmithKline vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of GlaxoSmithKline with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$98.9B-6.55%17.3173.52%3.73%
StrongBuy$1.3T430.40%45.5483.63%0.49%
StrongBuy$517.6B146.05%50.0673.72%2.36%
Buy$680.2B71.61%42.3067.56%1.87%
StrongBuy$286.8B60.70%25.6177.59%1.76%

Stock Returns calculator for GlaxoSmithKline Stock including INR - Dollar returns

The GlaxoSmithKline stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

GlaxoSmithKline investment value today

Current value as on today

₹1,08,721

Returns

₹8,721

(+8.72%)

Returns from GlaxoSmithKline Stock

₹3,129 (+3.13%)

Dollar Impact

₹5,592 (+5.59%)

Analyst Recommendation on GlaxoSmithKline Stock

Based on 33 analysts

BUY

60.61%

Buy

30.30%

Hold

9.09%

Sell

Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for GlaxoSmithKline. Average target price of $59.12

GlaxoSmithKline Share Price Target

Get share price movements and forecasts by analysts on GlaxoSmithKline.

What analysts predicted

19.16%UPSIDE

Target Price

$59.12

Current Price

$47.79

Analyzed by

33 Analysts

Target

$59.12

GlaxoSmithKline target price $59.12, a slight upside of 19.16% compared to current price of $47.79. According to 33 analysts rating.

Indian Investors' Interest in GlaxoSmithKline Stock

Search interest for GlaxoSmithKline Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:66% versus previous 30 day period

GlaxoSmithKline Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
7,884
8,012
8,117
7,516
7,986
8,547
8,618
7,629
8,409
8,817
Gross Profit
5,762
5,615
5,558
5,579
5,821
6,289
5,961
5,754
6,143
6,564
Operating Income
1,646
189
696
2,216
2,023
2,593
1,506
2,293
481
2,548
EBITDA
2,308
1,171
1,119
3,093
3,230
3,361
1,906
2,774
760
3,283
Interest Expense
174
156
144
162
184
167
174
167
182
217
Depreciation
639
951
412
823
1,159
738
782
463
224
735
Income Before Tax
1,495
64
563
2,108
1,887
2,456
950
2,144
354
1,919
Income Tax Expense
191
-1
62
336
241
312
223
305
-199
230
Net Income
1,173
-58
414
1,624
1,443
2,013
636
1,737
435
1,530
Net Profit Margin
73.08%
70.08%
68.47%
74.23%
72.89%
73.58%
69.17%
75.42%
73.05%
74.46%

GlaxoSmithKline Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
30,186
30,821
33,754
24,354
24,696
29,324
30,328
31,376
32,667
Gross Profit
19,844
20,580
21,891
16,425
16,533
19,770
21,763
22,328
23,650
Operating Income
4,087
5,483
6,961
5,979
4,357
6,433
6,745
4,021
7,932
EBITDA
6,184
7,350
9,434
8,067
6,485
8,564
9,150
6,668
10,373
Interest Expense
734
743
912
892
784
789
792
657
658
Depreciation
1,922
1,856
2,334
2,050
2,122
2,147
2,294
2,551
2,314
Income Before Tax
3,525
4,800
6,221
5,170
3,599
5,628
6,064
3,477
7,401
Income Tax Expense
1,356
754
953
67
83
707
756
526
1,112
Net Income
1,532
3,623
4,645
5,749
4,385
14,956
4,928
2,575
5,716
Net Profit Margin
65.74%
66.77%
64.85%
67.44%
66.95%
67.42%
71.76%
71.16%
72.40%

GlaxoSmithKline Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
1,304
65
501
1,772
1,646
2,714
627
1,839
437
1,530
Operating Cash Flow
1,113
2,154
2,329
1,145
2,096
3,027
2,036
1,141
2,535
2,786
Investing Cash Flow
770
-731
-1,119
-1,144
-625
-2,150
-2,362
-1,466
-880
-7,734
Financing Cash Flow
-1,584
-1,240
-842
858
-2,372
-1,706
808
272
-1,903
4,720
Change in Cash
291
149
375
848
-927
-494
97
-51
-312
-164

GlaxoSmithKline Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,169
4,046
5,268
5,103
3,516
5,494
5,308
2,951
6,289
Operating Cash Flow
6,918
8,421
8,020
8,441
7,952
8,160
6,768
6,554
7,741
Investing Cash Flow
-1,443
-1,553
-5,354
2,161
-1,777
-10,881
-1,595
-1,229
-4,233
Financing Cash Flow
-6,380
-6,389
-1,840
-10,132
-7,589
2,048
-5,641
-4,726
-3,685
Change in Cash
-1,005
487
744
431
-1,443
-1,310
-567
545
-196

Global Institutional Holdings in GlaxoSmithKline

Check out the Institutions with significant holdings in GlaxoSmithKline.

Funds
Holdings
Shares Held
John A. Gunn
2.13%
43183117
Dodge & Cox Funds
1.94%
39174382
Ken Fisher
1.75%
35351693
Theofanis Kolokotrones
1.25%
25192138
VANGUARD CHESTER FUNDS
0.90%
18172650

GlaxoSmithKline News & Key Events

  • img

    Today's Timeline - 17 November

    Tue, 03:42 PM

    -

    GSK targets £40 billion in sales by 2031, offsetting patent expirations with new medicines.

    Tue, 09:34 PM

    -

    GSK executives acquire shares through dividend reinvestment, signaling confidence in the company.

    Tue, 10:01 PM

    -

    GSK updates on COPD study, aiming to expand treatment options amid competitive market.

  • img

    Today's Timeline - 17 November

    Wed, 00:30 AM

    -

    GSK receives FDA accelerated approval for Nelkarmi, a lung cancer treatment, ahead of the original target date.

Insights on GlaxoSmithKline

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    GSK plc American Depositary Shares (ADS) have shown positive revenue performance over the last three quarters. The revenue increased from $7.62 billion to $8.81 billion, marking an average growth of 7.0% per quarter.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    GSK plc American Depositary Shares have shown strong profit growth over the last two quarters. The net profit increased from $434.99 million to $1.53 billion, which represents an average increase of 71.6% per quarter.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GSK has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, GSK stock has moved up by 38.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Merck & Co., Inc. has given 45.0% return, outperforming this stock by 40.2%

About GlaxoSmithKline

GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
OrganisationGlaxoSmithKline
Headquarters79 New Oxford Street, London, GL, WC1A 1DG, GB
IndustryDrug Manufacturers - General
CEOLuke Victor Miels

Key Management of GlaxoSmithKline

Name

Title

Ms. Julie Belita Brown A.C.A.

CFO & Executive Director

Dr. Jesse L. Goodman M.D., M.P.H.

Scientific & Medical Expert

Mr. Jeff McLaughlin

VP of Investor Relations & Interim Head of Investor Relations

Mr. David Simon Redfern BSc (Hons), CA

President of Corporate Development

Mr. Philip C. Thomson

President of Global Affairs

Mr. Luke Victor Miels

CEO & Director

Ms. Shobie Ramakrishnan

Chief Digital & Technology Officer

Mr. Tony Wood

Chief Scientific Officer and Head of R&D

Mr. James Ford

Senior VP and Group General Counsel of Legal & Compliance

Ms. Roanne Parry

Chief People Officer

FAQs

What is GlaxoSmithKline share price today?

GlaxoSmithKline share price today is $47.79 as on . GlaxoSmithKline share today touched a day high of $48.44 and a low of $47.68.

What is the 52 week high and 52 week low for GlaxoSmithKline share?

GlaxoSmithKline share touched a 52 week high of $61.70 on and a 52 week low of $45.81 on . GlaxoSmithKline stock price today i.e. is trending at $47.79,which is 22.54% down from its 52 week high and 4.33% up from its 52 week low.

What is GlaxoSmithKline's market capitalisation today?

GlaxoSmithKline market capitalisation is $0.10T as on .

How to invest in GlaxoSmithKline Stock (GSK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for GlaxoSmithKline on INDmoney app. Click on Buy button.

What is the minimum amount required to buy GlaxoSmithKline Stock (GSK) from India?

Indian investors can start investing in GlaxoSmithKline (GSK) shares with as little as ₹93.29000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.90 in GlaxoSmithKline stock (as per the Rupee-Dollar exchange rate as on ). Based on GlaxoSmithKline share’s latest price of $47.79 as on November 20, 2026 at 2:01 am IST, you will get 0.2092 shares of GlaxoSmithKline. Learn more about fractional shares .

What are the returns that GlaxoSmithKline has given to Indian investors in the last 5 years?

GlaxoSmithKline stock has given -6.55% share price returns and 26.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?